Healthy Clinical Trial
Official title:
To Determine the Degree of Association Between Heat Pain Detection Threshold and Area of Secondary Hyperalgesia Following Brief Thermal Sensitization in Healthy Male Volunteers
The purpose of this prospective study is to investigate how close Heat Pain Detection
Threshold is associated with the area of secondary hyperalgesia, elicited by the clinical
pain model Brief Thermal Sensitization.
Furthermore we wish to investigate how close the clinical pain model: Pain during 1 min.
heating of the skin (45 degrees celsius), and the psychological tests, Pain Catastrophizing
Scale and Hospital Anxiety and Depression Scale are associated with the area of secondary
hyperalgesia, elicited by the clinical pain model Brief Thermal Sensitization.
The study participants will be tested with 3 types of clinical pain models on two separate
identical study days. A minimum of 7 days will separate the two study days, thus, the
minimum length of the study is 7 days, but can be higher.
The 3 types of pain conditioning consist of 1) Brief thermal sensitisation (BTS), 2) Heat
pain detection threshold (HPDT), and pain during 1 min. thermal stimulation (p-TS.
The order of the stimulations (HPDT and BTS) is randomised for each patient and each study
day, by a random allocation sequence, computer-generated by Copenhagen Trial Unit and stored
in sealed and opaque envelopes to secure adequate allocation concealment. p-TS is conducted
subsequent to BTS and HPDT.
The participants will complete the psychological tests Pain Catastrophizing Scale (PCS) and
Hospital Anxiety and Depression Scale (HADS) in their private home prior to study day 1. The
completed tests will be placed in opaque sealed envelopes to secure blinding of the
investigator and outcome assessor.
;
Intervention Model: Single Group Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Basic Science
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |